HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody.

Abstract
Progressing tumors in man and mouse are often infiltrated by dendritic cells (DCs). Deficient antitumor immunity could be related to a lack of tumor-associated antigen (TAA) presentation by tumor-infiltrating DCs (TIDCs) or to a functional defect of TIDCs. Here we investigated the phenotype and function of TIDCs in transplantable and transgenic mouse tumor models. Although TIDCs could encompass various known DC subsets, most had an immature phenotype. We observed that TIDCs were able to present TAA in the context of major histocompatibility complex class I but that they were refractory to stimulation with the combination of lipopolysaccharide, interferon gamma, and anti-CD40 antibody. We could revert TIDC paralysis, however, by in vitro or in vivo stimulation with the combination of a CpG immunostimulatory sequence and an anti-interleukin 10 receptor (IL-10R) antibody. CpG or anti-IL-10R alone were inactive in TIDCs, whereas CpG triggered activation in normal DCs. In particular, CpG plus anti-IL-10R enhanced the TAA-specific immune response and triggered de novo IL-12 production. Subsequently, CpG plus anti-IL-10R treatment showed robust antitumor therapeutic activity exceeding by far that of CpG alone, and elicited antitumor immune memory.
AuthorsAlain P Vicari, Claudia Chiodoni, Céline Vaure, Smina Aït-Yahia, Christophe Dercamp, Fabien Matsos, Olivier Reynard, Catherine Taverne, Philippe Merle, Mario P Colombo, Anne O'Garra, Giorgio Trinchieri, Christophe Caux
JournalThe Journal of experimental medicine (J Exp Med) Vol. 196 Issue 4 Pg. 541-9 (Aug 19 2002) ISSN: 0022-1007 [Print] United States
PMID12186845 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adjuvants, Immunologic
  • Antibodies, Monoclonal
  • Antigens, Tumor-Associated, Carbohydrate
  • CD40 Antigens
  • CPG-oligonucleotide
  • Lipopolysaccharides
  • Oligodeoxyribonucleotides
  • Receptors, Interleukin
  • Receptors, Interleukin-10
  • Interferon-gamma
Topics
  • Adjuvants, Immunologic
  • Animals
  • Antibodies, Monoclonal (immunology)
  • Antigens, Tumor-Associated, Carbohydrate (immunology)
  • CD40 Antigens (immunology)
  • CD8-Positive T-Lymphocytes (immunology)
  • CpG Islands (immunology)
  • Dendritic Cells (cytology, immunology)
  • Female
  • Immunity, Active (immunology)
  • Immunity, Innate (immunology)
  • Immunologic Memory (immunology)
  • Interferon-gamma (immunology, pharmacology)
  • Killer Cells, Natural (immunology)
  • Lipopolysaccharides (immunology, pharmacology)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, SCID
  • Oligodeoxyribonucleotides (immunology, pharmacology)
  • Receptors, Interleukin (immunology)
  • Receptors, Interleukin-10
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: